Paper36722147
Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
Bebia Z and 27 others. J Infect Dis, 2023. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial. Papers, record 36722147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36722147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
- PubMed
- Publication types
- Randomized Controlled Trial, Clinical Trial, Phase II, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Respiratory Syncytial Virus Vaccines | Major topic |
| Respiratory Syncytial Virus Infections | Major topic |
| Respiratory Syncytial Virus, Human | Major topic |
| Pregnancy | |
| Humans | |
| Female | |
| Infant | |
| Infant, Newborn | |
| Adolescent | |
| Young Adult | |
| Adult | |
| Antibodies, Viral | |
| Antibodies, Neutralizing | |
| Mothers | |
| Viral Fusion Proteins | |
| Placenta | |
| Immunogenicity, Vaccine |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04126213 | Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants | Derived from the trial | Yes |
Source ClinicalTrials.gov
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35942656 | Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022. | BJOG | 2022 | https://conductscience.org/library/papers/35942656 | PubMed |
| 2 | 25070304 | Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. | Pediatrics | 2014 | https://conductscience.org/library/papers/25070304 | PubMed |
| 3 | 35598608 | Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35598608 | PubMed |
| 4 | 30107412 | Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness. | J Infect Dis | 2019 | https://conductscience.org/library/papers/30107412 | PubMed |
| 5 | 32463443 | Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32463443 | PubMed |
| 6 | 32726529 | Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32726529 | PubMed |
| 7 | 30913173 | Maternal Immunization. | Obstet Gynecol | 2019 | https://conductscience.org/library/papers/30913173 | PubMed |
| 8 | 17015575 | Diagnosis and management of bronchiolitis. | Pediatrics | 2006 | https://conductscience.org/library/papers/17015575 | PubMed |
| 9 | 27751641 | Global alignment of immunization safety assessment in pregnancy - The GAIA project. | Vaccine | 2016 | https://conductscience.org/library/papers/27751641 | PubMed |
| 10 | 26070108 | Novel antigens for RSV vaccines. | Curr Opin Immunol | 2015 | https://conductscience.org/library/papers/26070108 | PubMed |
| 11 | 24179220 | Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. | Science | 2013 | https://conductscience.org/library/papers/24179220 | PubMed |
| 12 | 23906887 | Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. | Vaccine | 2013 | https://conductscience.org/library/papers/23906887 | PubMed |
| 13 | 34146100 | Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women. | J Infect Dis | 2022 | https://conductscience.org/library/papers/34146100 | PubMed |
| 14 | 29308916 | Maternal immunization: where are we now and how to move forward? | Ann Med | 2018 | https://conductscience.org/library/papers/29308916 | PubMed |
| 15 | 23325327 | Respiratory syncytial virus entry inhibitors targeting the F protein. | Viruses | 2013 | https://conductscience.org/library/papers/23325327 | PubMed |
| 16 | 12850361 | Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. | Vaccine | 2003 | https://conductscience.org/library/papers/12850361 | PubMed |
| 17 | 31371616 | A proof of concept for structure-based vaccine design targeting RSV in humans. | Science | 2019 | https://conductscience.org/library/papers/31371616 | PubMed |
| 18 | 31278106 | Prevalence and risk of pre-eclampsia and gestational hypertension in twin pregnancies: a population-based register study. | BMJ Open | 2019 | https://conductscience.org/library/papers/31278106 | PubMed |
| 19 | 28574729 | Respiratory syncytial virus: prospects for new and emerging therapeutics. | Expert Rev Respir Med | 2017 | https://conductscience.org/library/papers/28574729 | PubMed |
| 20 | 31402384 | Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants. | J Infect Dis | 2019 | https://conductscience.org/library/papers/31402384 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42827513 | Efficacy and safety of maternal RSV vaccination against infant lower respiratory tract infections: a systematic review and meta-analysis. | Front Public Health | 2026 | https://conductscience.org/library/papers/42827513 | PubMed |
| 42761810 | Maternal RSV vaccination: clinical efficacy, safety, and global policy considerations: a systematic review. | J Pharm Policy Pract | 2026 | https://conductscience.org/library/papers/42761810 | PubMed |
| 42712161 | RSV-Pre-F Vaccination During Pregnancy and Neonatal Outcomes-A Systematic Review and Meta-Analysis. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/42712161 | PubMed |
| 42523462 | CAUSAL-RSV: A study protocol for a causal mediation analysis of RSV vaccine effects in infants using real-world data. | medRxiv | 2026 | https://conductscience.org/library/papers/42523462 | PubMed |
| 42411551 | Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches. | J Med Virol | 2026 | https://conductscience.org/library/papers/42411551 | PubMed |
| 41975207 | The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials. | J Perinatol | 2026 | https://conductscience.org/library/papers/41975207 | PubMed |
| 41784331 | Introducing the Concept of Small Vulnerable Newborns (SVN) as an Additional Endpoint to Evaluate Birth Outcomes in the Context of RSV Immunization Studies-A Commentary. | Influenza Other Respir Viruses | 2026 | https://conductscience.org/library/papers/41784331 | PubMed |
| 41766205 | Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41766205 | PubMed |
| 41721455 | Maternal RSV immunization: clinical efficacy, immunological mechanisms and public health implications for preventing infant lower respiratory tract infection. | J Health Popul Nutr | 2026 | https://conductscience.org/library/papers/41721455 | PubMed |
| 41590244 | Real-World Evidence Evaluation of Respiratory Syncytial Virus (RSV) Vaccines: Deep Dive into Vaccine Adverse Events Reporting System. | Diseases | 2026 | https://conductscience.org/library/papers/41590244 | PubMed |
| 41455011 | Maternal RSV vaccine: a systematic review and meta-analysis of immunogenicity and perinatal safety. | Immunol Res | 2025 | https://conductscience.org/library/papers/41455011 | PubMed |
| 41395311 | Epidemiological characteristics and disease burden of childhood neuroblastoma in Asia: trends and regional differences over the past 30 years. | Front Pediatr | 2025 | https://conductscience.org/library/papers/41395311 | PubMed |
| 41295543 | Evaluation of the Safety and Efficacy of the Respiratory Syncytial Virus FG Chimeric Vaccine KD-409 in Rodent Models for Maternal and Pediatric Vaccination. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295543 | PubMed |
| 41286483 | Position statement of the Mexican Association of Pediatrics on the immunoprevention of respiratory syncytial virus infection during pregnancy and infancy. | World J Pediatr | 2026 | https://conductscience.org/library/papers/41286483 | PubMed |
| 41221171 | Safety and efficacy of maternal RSV vaccination: a systematic review and meta-analysis. | Clin Exp Vaccine Res | 2025 | https://conductscience.org/library/papers/41221171 | PubMed |
| 40944041 | Epidemiological Changes in Pediatric RSV Infections in Poland (2016-2024): Impact of the COVID-19 Pandemic. | J Clin Med | 2025 | https://conductscience.org/library/papers/40944041 | PubMed |
| 40899087 | Natural Killer Cells Are Dispensable for Virus Control in Rag2-/- Mice During Primary RSV Infection. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40899087 | PubMed |
| 40821247 | Side Effects Associated With Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccination: A Scoping Review. | Cureus | 2025 | https://conductscience.org/library/papers/40821247 | PubMed |
| 40420998 | Respiratory syncytial virus: health burden, disease prevention, and treatment-recent progress and lessons learned. | Microlife | 2025 | https://conductscience.org/library/papers/40420998 | PubMed |
| 40240559 | Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/40240559 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36722147
GET https://conductscience.org/api/papers/v1/36722147/authors?page=2